Roivant Sciences Statistics
NASDAQ: ROIVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
34.97+0.76 (+2.22%)
Market open · Delayed 15 min · as of Oct 9, 12:53 PM ET
Roivant Sciences by the numbers
Roivant Sciences has a market capitalization of $25.26 billion based on 722.32M shares outstanding. With trailing EPS of $-0.53, Roivant Sciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.6% below its 50-day average and 14.9% above its 200-day average.
Average daily trading volume is 7.04M shares, or about $246.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ROIV valuation vs. peer median
| Metric | ROIV | Peer median | Difference |
|---|---|---|---|
| Market cap | $25.26B | $23.15B | +9% |
| Avg. volume | 7.04M | 2.71M | +159% |
Peer median across 8 companies: UTHR, GMAB, INSM, VTRS, ZTS, ALNY, RPRX, ASND.
Valuation
- Market cap
- $25.26B
- Price / sales (latest FY)
- 3,058.07
- EPS (TTM)
- $-0.53
- Shares outstanding
- 722.32M
Price and trading
- Previous close
- 34.21
- Open
- 34.24
- Day range
- 34.15 – 35.02
- 52-week range
- 15.90 – 42.50
- 52-week change
- +113.41%
- Beta
- —
- Volume
- 1.02M
- Average volume
- 7.04M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 25.26B
- Forward Pe
- -20.36
- Eps
- -0.53
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 42.50
- Week52 Low
- 15.90
- Avg Volume
- 7.04M
- Shares Outstanding
- 722.32M
- Ma50
- 36.66
- Ma200
- 30.43
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -17.72%
- Pct From52w Low
- 119.94%